More recent research has also used human fibroblast-derived induced neurons
The FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed
Previous clinical studies have found that individuals with concurrent T2DM and asthma treated with GLP-1RAs experience decreased asthma exacerbations, asthma-related hospitalizations, and overall increased asthma control [8,9,10]
Preclinical studies suggest that its primary mechanism involves modulating local growth factor expression, upregulating vascular endothelial growth factor receptor 2 (VEGFR2), and promoting cellular migration to sites of mechanical or inflammatory injury
Reducing Inflammation: Mitigates inflammation, which aids in faster recovery and pain relief